Jazz Pharmaceuticals (JAZZ) Revenue (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.77% |
| Dec 31, 2025 | 6.38% |
| Sep 30, 2025 | 7.69% |
| Jun 30, 2025 | 16.47% |
| Mar 31, 2025 | -17.49% |
| Dec 31, 2024 | 3.15% |
| Sep 30, 2024 | 3.04% |
| Jun 30, 2024 | 13.51% |
| Mar 31, 2024 | -10.87% |
| Dec 31, 2023 | 4.09% |
| Sep 30, 2023 | 1.55% |
| Jun 30, 2023 | 7.22% |
| Mar 31, 2023 | -8.16% |
| Dec 31, 2022 | 3.35% |
| Sep 30, 2022 | 0.83% |
| Jun 30, 2022 | 14.64% |
| Mar 31, 2022 | -9.26% |
| Dec 31, 2021 | 6.99% |
| Sep 30, 2021 | 11.48% |
| Jun 30, 2021 | 23.74% |
| Mar 31, 2021 | -8.71% |
| Dec 31, 2020 | 10.76% |
| Sep 30, 2020 | 6.84% |
| Jun 30, 2020 | 5.18% |
| Mar 31, 2020 | -8.08% |
| Dec 31, 2019 | 8.19% |
| Sep 30, 2019 | 0.67% |
| Jun 30, 2019 | 5.11% |
| Mar 31, 2019 | 6.66% |
| Dec 31, 2018 | 1.51% |
| Sep 30, 2018 | -6.22% |
| Jun 30, 2018 | 12.57% |
| Mar 31, 2018 | 1.88% |
| Dec 31, 2017 | 5.96% |
| Sep 30, 2017 | 4.43% |
| Jun 30, 2017 | 4.88% |
| Mar 31, 2017 | -5.19% |
| Dec 31, 2016 | 6.00% |
| Sep 30, 2016 | -1.83% |
| Jun 30, 2016 | 13.44% |
| Mar 31, 2016 | -1.43% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 2.13% |
| Jun 30, 2015 | 7.90% |
| Mar 31, 2015 | -5.74% |
| Dec 31, 2014 | 7.03% |
| Sep 30, 2014 | 5.27% |
| Jun 30, 2014 | 17.95% |
| Mar 31, 2014 | 4.73% |
| Dec 31, 2013 | 1.56% |
| Sep 30, 2013 | 11.48% |
| Jun 30, 2013 | 6.12% |
| Mar 31, 2013 | 6.82% |
| Dec 31, 2012 | 4.67% |
| Sep 30, 2012 | 41.28% |
| Jun 30, 2012 | 21.17% |
| Mar 31, 2012 | 22.74% |
| Dec 31, 2011 | 15.68% |
| Sep 30, 2011 | 13.79% |
| Jun 30, 2011 | 24.73% |
| Mar 31, 2011 | -39.09% |
| Dec 31, 2010 | 13.98% |
| Sep 30, 2010 | 13.51% |